Latest updates

New or recently updated pages

1 Follow-up and monitoring for people with obesity hypoventilation syndrome (OHS)
2 Obesity hypoventilation syndrome
3 NICE guidance - treatments for obesity hypoventilation syndrome (OHS)
4 Prioritising people for rapid assessment by a sleep service - obesity hypoventilation syndrome (OHS)
5 Obesity hypoventilation syndrome (OHS)
6 NICE guidance - positional modifiers for OSAHS (obstructive sleep apnoea/hypopnoea syndrome)
7 NICE guidance - treatments for moderate and severe OSAHS (obstructive sleep apnoea/hypopnoea syndrome)
8 NICE guidance - treatments for mild OSAHS (obstructive sleep apnoea/hypopnoea syndrome)
9 Positional OSAHS (Obstructive sleep apnoea/hypopnoea syndrome)
10 Obstructive sleep apnoea - hypopnoea syndrome (OSAHS)

Trending topics

Most popular pages in the past week

1 HRT
2 Migraine
3 Gout
4 Hand foot and mouth disease
5 Acne vulgaris
6 PCOS
7 Systemic hypertension
8 Menopause
9 Exclusion from school (guidance re: common infections)
10 Fibromyalgia syndrome (FMS)

Introducing

GPn Pro logo
  • Checkmark icon Track your pages, video views and more
  • Checkmark icon Accumulate CPD credits while you work
  • Checkmark icon Add reflective notes
  • Checkmark icon Export your yearly CPD statement
  • Checkmark icon Access premium content
Upgrade now

From the Editor-in-Chief

Welcome to GPnotebook – a concise synopsis of clinical medicine focused on the needs of the general practitioner, which aims to help you make fast, evidence-based decisions.

We’re pleased to announce the launch of GPnotebook Pro – a subscription service that makes it quick and easy for you to build your yearly CPD portfolio through your activity with GPnotebook during consultations and at other times. In addition, GPnotebook Pro users have access to a growing library of exclusive content.

To support the launch of GPnotebook Pro, we have collaborated with InterACT Medical Education, a CPD-accredited non-promotional medical education resource provided by AstraZeneca. The support provided by AstraZeneca will enable UK healthcare professionals to register to access GPnotebook Pro without charge for a period of 6 months. AstraZeneca has no editorial input into or control over the content of GPnotebook. Click here to find out how to start your 6-month introductory free access period.

We hope you find GPnotebook Pro helpful, and as always, if you have any comments or criticisms, please do not hesitate to contact us.

Best,
Dr Jim McMorran
Dr Jim McMorran
Co-founder and Editor-in-Chief, GPnotebook

GPnTV logo

Quick video updates on the clinical developments that matter most

Watch now
GPn Podcast logo

A bite-sized, regular chat for all healthcare professionals working in primary care

Listen now